Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR Technology for Ocular Angiogenesis

22 Dec 2020

Abstract excerpt

Among genome engineering tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based approaches have been widely adopted for translational studies due to their robustness, precision, and ease of use. When delivered to diseased tissues with a viral vector such as adeno-associated virus, direct genome editing can be efficiently achieved in vivo to treat different ophthalmic conditions. While...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34713223
DOI: 10.3389/fgeed.2020.594984

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR Technology for Ocular AngiogenesisPMID 34713223Read ↗

Targeting vascular endothelial growth factor using retinal gene therapySemantic proximity Read ↗

Genome editing abrogates angiogenesis in vivoSemantic proximity Read ↗

Genome Editing VEGFA Prevents Corneal Neovascularization In VivoSemantic proximity Read ↗

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Semantic proximity Read ↗

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseasesSemantic proximity Read ↗

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseasesSemantic proximity Read ↗

Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal NeovascularizationSemantic proximity Read ↗

CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularizationSemantic proximity Read ↗

Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyesSemantic proximity Read ↗

CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.Semantic proximity Read ↗

Genomic Disruption of VEGF-A Expression in Human Retinal Pigment Epithelial Cells Using CRISPR-Cas9 Endonuclease.Semantic proximity Read ↗

CRISPR Interference-Potential Application in Retinal Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.